Stock listing
OTC:CYTOF Altamira Therapeutics Ltd. Stock
Follow Altamira Therapeutics Ltd. into a list and get an email when it puts out news.
Share price · OTC:CYTOF
$0.071 USD 0.000 (0.0%)
Close on Nov 18, 2026
Past year -21.3% · daily closes, Nov 18, 2025 – Nov 18, 2026, adjusted for splits- Day range
- $0.071 – $0.071 USDNov 18, 2026
- Volume
- 1,856 sharesNov 18, 2026
- Market cap
- $404,655 USDAt the close on Nov 18, 2026 · price × 5.72M shares outstanding
- 52-week range
- $0.050 – $0.147 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $351 USDMedian day 400 shares · 19 days with no trades · last 3 months, Aug 18, 2026 – Nov 18, 2026
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OTC:CYTOF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|
| $0.071 | 0.000 | 0.0% | $0.071 | $0.071 | $0.071 | 1,856 |
|---|
| $0.071 | 0.000 | 0.0% | $0.071 | $0.071 | $0.071 | 329 |
|---|
| $0.071 | -0.001 | -1.7% | $0.071 | $0.071 | $0.071 | 150 |
|---|
| $0.072 | -0.028 | -28.0% | $0.083 | $0.083 | $0.072 | 2,100 |
|---|
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 0 |
|---|
| $0.100 | 0.000 | 0.0% | $0.100 | $0.100 | $0.100 | 0 |
|---|
| $0.100 | +0.029 | +40.8% | $0.100 | $0.100 | $0.100 | 4,000 |
|---|
| $0.071 | 0.000 | 0.0% | $0.071 | $0.071 | $0.071 | 0 |
|---|
| $0.071 | -0.032 | -31.1% | $0.071 | $0.071 | $0.071 | 1,600 |
|---|
| $0.103 | +0.033 | +47.1% | $0.090 | $0.103 | $0.080 | 12,200 |
|---|
| $0.070 | -0.030 | -30.0% | $0.110 | $0.110 | $0.070 | 4,000 |
|---|
| $0.100 | +0.031 | +44.9% | $0.100 | $0.100 | $0.100 | 20,800 |
|---|
| $0.069 | -0.016 | -18.8% | $0.069 | $0.069 | $0.069 | 1,800 |
|---|
| $0.085 | 0.000 | 0.0% | $0.085 | $0.085 | $0.085 | 0 |
|---|
| $0.085 | 0.000 | 0.0% | $0.085 | $0.085 | $0.085 | 0 |
|---|
| $0.085 | 0.000 | 0.0% | $0.085 | $0.085 | $0.085 | 0 |
|---|
| $0.085 | -0.005 | -5.6% | $0.085 | $0.085 | $0.085 | 1,600 |
|---|
| $0.090 | 0.000 | 0.0% | $0.090 | $0.090 | $0.090 | 0 |
|---|
| $0.090 | 0.000 | 0.0% | $0.090 | $0.090 | $0.090 | 0 |
|---|
| $0.090 | +0.010 | +12.5% | $0.080 | $0.090 | $0.080 | 65,400 |
|---|
| $0.080 | +0.006 | +8.1% | $0.080 | $0.080 | $0.080 | 1,800 |
|---|
| $0.074 | +0.012 | +19.4% | $0.063 | $0.074 | $0.058 | 4,400 |
|---|
| $0.062 | +0.007 | +12.7% | $0.062 | $0.062 | $0.062 | 400 |
|---|
| $0.055 | -0.014 | -20.3% | $0.058 | $0.058 | $0.055 | 1,800 |
|---|
| $0.069 | -0.020 | -22.5% | $0.065 | $0.070 | $0.065 | 500 |
|---|
| $0.089 | 0.000 | 0.0% | $0.089 | $0.089 | $0.089 | 0 |
|---|
| $0.089 | 0.000 | 0.0% | $0.089 | $0.089 | $0.089 | 0 |
|---|
| $0.089 | 0.000 | 0.0% | $0.089 | $0.089 | $0.089 | 800 |
|---|
| $0.089 | +0.014 | +18.7% | $0.070 | $0.089 | $0.070 | 8,100 |
|---|
| $0.075 | 0.000 | 0.0% | $0.075 | $0.075 | $0.075 | 0 |
|---|
| $0.075 | 0.000 | 0.0% | $0.075 | $0.075 | $0.075 | 0 |
|---|
| $0.075 | +0.020 | +36.4% | $0.069 | $0.075 | $0.069 | 200 |
|---|
| $0.055 | -0.017 | -23.6% | $0.055 | $0.055 | $0.055 | 200 |
|---|
| $0.072 | 0.000 | 0.0% | $0.072 | $0.072 | $0.072 | 0 |
|---|
| $0.072 | 0.000 | 0.0% | $0.072 | $0.072 | $0.072 | 0 |
|---|
| $0.072 | 0.000 | 0.0% | $0.072 | $0.072 | $0.072 | 0 |
|---|
| $0.072 | 0.000 | 0.0% | $0.072 | $0.072 | $0.072 | 535 |
|---|
| $0.072 | -0.017 | -19.1% | $0.072 | $0.072 | $0.072 | 400 |
|---|
| $0.089 | +0.039 | +78.0% | $0.089 | $0.089 | $0.089 | 500 |
|---|
| $0.050 | -0.039 | -43.8% | $0.050 | $0.050 | $0.050 | 300 |
|---|
| $0.089 | 0.000 | 0.0% | $0.089 | $0.089 | $0.089 | 0 |
|---|
| $0.089 | +0.038 | +74.5% | $0.050 | $0.089 | $0.050 | 500 |
|---|
| $0.051 | +0.001 | +2.0% | $0.051 | $0.051 | $0.051 | 100 |
|---|
| $0.050 | -0.021 | -29.6% | $0.050 | $0.050 | $0.050 | 8,000 |
|---|
| $0.071 | 0.000 | 0.0% | $0.071 | $0.071 | $0.071 | 2 |
|---|
| $0.071 | -0.003 | -4.1% | $0.077 | $0.077 | $0.071 | 12,000 |
|---|
| $0.074 | +0.003 | +4.2% | $0.071 | $0.074 | $0.063 | 12,100 |
|---|
| $0.071 | 0.000 | 0.0% | $0.071 | $0.071 | $0.071 | 2 |
|---|
| $0.071 | 0.000 | 0.0% | $0.089 | $0.089 | $0.066 | 67,000 |
|---|
| $0.071 | 0.000 | 0.0% | $0.071 | $0.071 | $0.071 | 28 |
|---|
| $0.071 | -0.013 | -15.5% | $0.071 | $0.071 | $0.071 | 15,100 |
|---|
| $0.084 | +0.014 | +20.0% | $0.084 | $0.084 | $0.084 | 6,200 |
|---|
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 0 |
|---|
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 0 |
|---|
| $0.070 | 0.000 | 0.0% | $0.070 | $0.070 | $0.070 | 0 |
|---|
| $0.070 | -0.001 | -1.4% | $0.065 | $0.074 | $0.065 | 3,200 |
|---|
| $0.071 | +0.007 | +10.9% | $0.070 | $0.071 | $0.064 | 1,500 |
|---|
| $0.064 | 0.000 | 0.0% | $0.064 | $0.064 | $0.064 | 2 |
|---|
| $0.064 | 0.000 | 0.0% | $0.064 | $0.064 | $0.064 | 700 |
|---|
| $0.064 | 0.000 | 0.0% | $0.064 | $0.064 | $0.064 | 100 |
|---|
| $0.064 | -0.006 | -8.6% | $0.064 | $0.064 | $0.064 | 5,000 |
|---|
Splits
4 splits since 2018 · OTC:CYTOF · every price before a split is adjusted for it
| Day | Ratio | What |
|---|
| 1-for-20 | Consolidation |
|---|
| 1-for-20 | Consolidation |
|---|
| 1-for-20 | Consolidation |
|---|
| 1-for-10 | Consolidation |
|---|
- Ticker
- OTC:CYTOF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Altamira Therapeutics Ltd. on 6ix
- Decks
- 7 decks · latest Mar 8, 2023
Valuation
Price/book 0.1× against a median of 0.2×: 3rd lowest of 8 Biotechnology companies shown. balance Jun 30, 2025 · price Nov 18, 2026
- Enterprise value
- $400,900 USD
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.1×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.64
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|
| Altamira Therapeutics Ltd. · OTC:CYTOF | US$404,655 | US$400,900 | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 0.64 |
|---|
| Oragenics Inc. · AMEX:OGEN | US$708,377 | −US$1.12M | n/a | n/a | n/a | 0.7× | n/a | 0.4× | 1.47 |
|---|
| Protagenic Therapeutics, Inc. · OTC:PTIX | US$687,879 | US$610,970 | 0.1× | n/a | n/a | 0.6× | n/a | 0.0× | 1.21 |
|---|
| Lakewood-Amedex Biotherapeutics Inc. · NASDAQ:LABT | US$580,337 | −US$2.74M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 0.46 |
|---|
| Mushrooms, Inc. · OTC:MSRM | US$539,339 | US$564,177 | n/a | n/a | n/a | n/a | n/a | n/a | 1.24 |
|---|
| Jaguar Health, Inc. · NASDAQ:JAGX | US$527,406 | −US$1.48M | n/a | −0.1× | n/a | 0.0× | −181.8% | 0.2× | 3.75 |
|---|
| NKGen Biotech Inc. · OTC:NKGN | US$391,807 | US$38.58M | n/a | n/a | n/a | n/a | n/a | n/a | 0.88 |
|---|
| Vaxil Bio Ltd. · TSXV:VXL | US$319,477 | −US$4,071 | 1.2× | n/a | n/a | 0.4× | n/a | 0.0× | -0.16 |
|---|
| Chimeric Therapeutics Limited · ASX:CHM | US$293,048 | −US$220,369 | n/a | −0.1× | n/a | 0.2× | −262.8% | 2.5× | n/a |
|---|
| CERo Therapeutics Holdings, Inc. · OTC:CERO | US$265,035 | −US$190,890 | n/a | n/a | n/a | n/a | n/a | n/a | 1.47 |
|---|
| CDT Equity Inc. · NASDAQ:CDT | US$234,109 | −US$1.49M | n/a | n/a | n/a | 0.0× | n/a | 0.0× | 1.14 |
|---|
| Median of the others | US$459,607 | −US$205,630 | 0.7× | −0.1× | | 0.2× | −222.3% | 0.0× | 1.21 |
|---|
Team and board
Officers
| Officer | Role |
|---|
| Thomas Meyer | Chairman of the Board, Chief Executive Officer |
|---|
| Marcel Gremaud | Chief Financial Officer |
|---|
| Covadonga Pañeda | Chief Operating Officer |
|---|
| Samuel A. Wickline | Chief Scientific Adviser |
|---|
Board
| Director | Role |
|---|
| Thomas Meyer | Chairman of the Board, Chief Executive Officer |
|---|
| Alain Munoz | Director |
|---|
| Dominik Lysek | Director |
|---|
Events
| Quarter | Results | Share move |
|---|
| Q2 2025 | Aug 29, 2025 | 0.0% |
|---|
| Quarter to Mar 31, 2025 | Apr 30, 2025 | −12.5% |
|---|
| Q2 2024 | Sep 24, 2024 | +0.3% |
|---|
| Quarter to Sep 30, 2022 | Nov 17, 2022 | −11.4% |
|---|
| Quarter to Jun 30, 2022 | Aug 18, 2022 | −4.2% |
|---|
| Quarter to Mar 31, 2022 | Apr 12, 2022 | −30.7% |
|---|
| Quarter to Sep 30, 2021 | Nov 18, 2021 | −17.7% |
|---|
| Quarter to Jun 30, 2021 | Sep 8, 2021 | +0.4% |
|---|
| Quarter to Mar 31, 2021 | May 18, 2021 | +5.0% |
|---|
| Quarter to Dec 31, 2020 | Mar 31, 2021 | +5.9% |
|---|
Open Events
IPO
Went public as Auris Medical Holding AG. Priced at US$6.00 a share on Aug 5, 2014.
- Price
- US$6.00 a share
- Shares offered
- 9,400,000 common shares
- Offering size
- US$56.4 million
- Underwriters' option
- Up to 1,410,000 more shares
- Underwriters
- Jefferies, Leerink Partners, JMP Securities, Needham & Company · In the order on the cover
- Shares delivered
- On or about Aug 11, 2014
Steps
| Step | When |
|---|
| Draft sent to the SEC in confidence | Mar 18, 2014 |
|---|
| Filed publicly | Jun 27, 2014 |
|---|
| Amended 3 times | Newest Aug 8, 2014 |
|---|
| Shares registered with an exchange | Jul 29, 2014 |
|---|
| Declared effective by the SEC | Aug 5, 2014 |
|---|
| Final prospectus, with the price | Aug 7, 2014 |
|---|
Filings
| Filing | Filed |
|---|
| EFFECT · Notice that a registration is effective | Aug 8, 2014 |
|---|
| POS AM · Amendment to an effective registration | Aug 8, 2014 |
|---|
| 424B4 · Prospectus | Aug 7, 2014 |
|---|
| EFFECT · Notice that a registration is effective | Aug 5, 2014 |
|---|
| CORRESP · Letter to the SEC | Aug 5, 2014 |
|---|
| CORRESP · Letter to the SEC | Aug 5, 2014 |
|---|
| FWP · Free writing prospectus | Aug 5, 2014 |
|---|
| F-1/A · Registration statement, amended | Aug 5, 2014 |
|---|
| CERTNAS · Nasdaq's certificate of listing | Jul 29, 2014 |
|---|
| 8-A12B · Registration of shares for listing on an exchange | Jul 29, 2014 |
|---|
All 22 filings
| Filing | Filed |
|---|
| CORRESP · Letter to the SEC | Jul 29, 2014 |
|---|
| CORRESP · Letter to the SEC | Jul 29, 2014 |
|---|
| F-1/A · Registration statement, amended | Jul 21, 2014 |
|---|
| UPLOAD · Letter from the SEC | Jul 16, 2014 |
|---|
| CORRESP · Letter to the SEC | Jul 14, 2014 |
|---|
| F-1 · Registration statement | Jun 27, 2014 |
|---|
| UPLOAD · Letter from the SEC | Jun 18, 2014 |
|---|
| DRS/A · Draft registration statement, amended | Jun 6, 2014 |
|---|
| DRSLTR · Letter to the SEC with a draft | Apr 18, 2014 |
|---|
| DRS/A · Draft registration statement, amended | Apr 18, 2014 |
|---|
| UPLOAD · Letter from the SEC | Apr 15, 2014 |
|---|
| DRS · Draft registration statement | Mar 18, 2014 |
|---|
Open IPO · From the cover of the final prospectus (424B4) filed Aug 7, 2014
Financials
Annual, in USD
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|
| Revenue | 0 | 0 | 0 | 0 | | | |
|---|
| Cost of revenue | | 268.9K | 1.56M | 2.45M | | | |
|---|
| Gross profit | | -80.6K | -1.23M | -2.38M | | | |
|---|
| Research and development | 3.73M | 3.38M | 15.3M | 3.50M | | | |
|---|
| Selling, general and administrative | 3.20M | 3.49M | 3.56M | 3.98M | | | |
|---|
| Operating income | -6.85M | -6.58M | -18.9M | -7.52M | | | |
|---|
| Depreciation and amortization | 127.1K | 132.8K | 124.5K | 83.5K | | | |
|---|
| EBITDA | -6.72M | -6.45M | -18.7M | -7.43M | | | |
|---|
| Interest expense | 0 | 1.12M | 934.0K | 15.4K | | | |
|---|
| Income before tax | -8.46M | -8.09M | -19.5M | -6.81M | | | |
|---|
| Income tax | | | -8.29K | 117.9K | | | |
|---|
| Net income | -8.46M | -4.31M | -27.8M | -18.7M | -8.20M | -6.63M | -11.5M |
|---|
| Earnings per share, basic | -2.99 | -8.77 | -610.03 | -498.82 | -14.36 | -1.61 | -6.47 |
|---|
| Earnings per share, diluted | -2.99 | -8.77 | -610.03 | | | | |
|---|
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|
| Cash and equivalents | 998.6K | 733.7K | 16.6K | 1.08M | | | |
|---|
| Receivables | 0 | 0 | 7.05K | 23.8K | | | |
|---|
| Inventory | 0 | 0 | 12.6K | 918.1K | | | |
|---|
| Current assets | 1.54M | 1.45M | 1.91M | 4.48M | | | |
|---|
| Property, plant and equipment | 100.0K | 1 | | | | | |
|---|
| Total assets | 8.65M | 9.14M | 6.81M | 21.0M | | | |
|---|
| Accounts payable | 552.0K | 523.4K | 5.31M | 3.88M | | | |
|---|
| Current liabilities | 1.16M | 1.06M | 13.9M | 5.32M | | | |
|---|
| Total debt | | 5.29M | | | | | |
|---|
| Total liabilities | 2.09M | 1.47M | 15.8M | 6.71M | | | |
|---|
| Shareholders' equity | 6.57M | 7.68M | -8.30M | 14.3M | | | |
|---|
| Shares outstanding | 4.66M | 1.48M | 59.0K | 37.4K | 570.9K | 4.13M | 1.78M |
|---|
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 |
|---|
| Cash from operations | -6.11M | -12.8M | -9.09M | -15.0M | | |
|---|
| Capital spending | -103.1K | 0 | -2.24M | -3.64M | 0 | 0 |
|---|
| Free cash flow | -6.22M | -11.5M | -11.3M | -18.6M | | |
|---|
| Cash from investing | -115.3K | 1.61M | -2.24M | | | |
|---|
| Cash from financing | 6.51M | 11.8M | 10.3M | 7.24M | | |
|---|
| Dividends paid | 0 | 0 | 0 | 0 | | |
|---|
| Change in cash | 276.3K | 618.2K | -1.04M | -11.6M | | |
|---|
Open Financials
Filings
| Filing | Date | Type | Filed with |
|---|
| 15-12G | Feb 27, 2026 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Aug 29, 2025 | Current report | SEC |
|---|
| 25-NSE | Jun 17, 2025 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 11, 2025 | Current report | SEC |
|---|
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
|---|
| 6-K · Report of a foreign issuer | May 9, 2025 | Current report | SEC |
|---|
| SCHEDULE 13D/A · Big-stake notice, amended | May 6, 2025 | Big-stake notice | SEC |
|---|
| 20-F · Annual report | Apr 30, 2025 | Annual report | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 30, 2025 | Current report | SEC |
|---|
| S-8 · Registration statement for employee plans | Apr 4, 2025 | Offer document | SEC |
|---|
Show 200 filings
| Filing | Date | Type | Filed with |
|---|
| 6-K · Report of a foreign issuer | Mar 10, 2025 | Current report | SEC |
|---|
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 20, 2024 | Current report | SEC |
|---|
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 4, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 24, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 19, 2024 | Current report | SEC |
|---|
| 424B4 · Prospectus | Sep 18, 2024 | Offer document | SEC |
|---|
| EFFECT · Notice that a registration is effective | Sep 18, 2024 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Sep 16, 2024 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Sep 16, 2024 | Other filings | SEC |
|---|
| F-1/A · Registration statement, amended | Sep 16, 2024 | Offer document | SEC |
|---|
| F-1/A · Registration statement, amended | Sep 16, 2024 | Offer document | SEC |
|---|
| UPLOAD · Letter from the SEC | Aug 28, 2024 | Other filings | SEC |
|---|
| F-1 · Registration statement | Aug 22, 2024 | Offer document | SEC |
|---|
| EFFECT · Notice that a registration is effective | Jul 15, 2024 | Other filings | SEC |
|---|
| POS AM · Amendment to an effective registration | Jul 8, 2024 | Offer document | SEC |
|---|
| 20-F/A · Annual report, amended | Jul 1, 2024 | Annual report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 16, 2024 | Current report | SEC |
|---|
| 20-F/A · Annual report, amended | Apr 22, 2024 | Annual report | SEC |
|---|
| EFFECT · Notice that a registration is effective | Apr 18, 2024 | Other filings | SEC |
|---|
| 424B4 · Prospectus | Apr 17, 2024 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 16, 2024 | Current report | SEC |
|---|
| UPLOAD · Letter from the SEC | Apr 16, 2024 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Apr 16, 2024 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 10, 2024 | Current report | SEC |
|---|
| S-8 · Registration statement for employee plans | Apr 10, 2024 | Offer document | SEC |
|---|
| F-1 · Registration statement | Apr 10, 2024 | Offer document | SEC |
|---|
| 20-F · Annual report | Apr 10, 2024 | Annual report | SEC |
|---|
| SC 13D/A · Big-stake notice, amended | Mar 13, 2024 | Big-stake notice | SEC |
|---|
| 424B4 · Prospectus | Jan 22, 2024 | Offer document | SEC |
|---|
| EFFECT · Notice that a registration is effective | Jan 22, 2024 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 19, 2024 | Current report | SEC |
|---|
| 424B5 · Prospectus | Jan 19, 2024 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 19, 2024 | Current report | SEC |
|---|
| CORRESP · Letter to the SEC | Jan 17, 2024 | Other filings | SEC |
|---|
| UPLOAD · Letter from the SEC | Jan 16, 2024 | Other filings | SEC |
|---|
| F-3 · Registration statement | Jan 8, 2024 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 11, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 11, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 8, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 22, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 21, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 31, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 4, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 12, 2023 | Current report | SEC |
|---|
| 6-K/A · Report of a foreign issuer, amended | Aug 21, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 28, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 26, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 11, 2023 | Current report | SEC |
|---|
| 424B4 · Prospectus | Jul 7, 2023 | Offer document | SEC |
|---|
| EFFECT · Notice that a registration is effective | Jul 6, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Jul 5, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Jul 5, 2023 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 3, 2023 | Current report | SEC |
|---|
| F-1/A · Registration statement, amended | Jul 3, 2023 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 30, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 27, 2023 | Current report | SEC |
|---|
| UPLOAD · Letter from the SEC | Jun 23, 2023 | Other filings | SEC |
|---|
| F-1 · Registration statement | Jun 16, 2023 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 15, 2023 | Current report | SEC |
|---|
| EFFECT · Notice that a registration is effective | Jun 12, 2023 | Other filings | SEC |
|---|
| EFFECT · Notice that a registration is effective | Jun 12, 2023 | Other filings | SEC |
|---|
| 424B3 · Prospectus | Jun 9, 2023 | Offer document | SEC |
|---|
| 424B3 · Prospectus | Jun 9, 2023 | Offer document | SEC |
|---|
| CORRESP · Letter to the SEC | Jun 9, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Jun 9, 2023 | Other filings | SEC |
|---|
| UPLOAD · Letter from the SEC | Jun 8, 2023 | Other filings | SEC |
|---|
| UPLOAD · Letter from the SEC | Jun 8, 2023 | Other filings | SEC |
|---|
| F-3 · Registration statement | Jun 1, 2023 | Offer document | SEC |
|---|
| F-1 · Registration statement | Jun 1, 2023 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | May 30, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 26, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 16, 2023 | Current report | SEC |
|---|
| 20-F · Annual report | May 16, 2023 | Annual report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 2, 2023 | Current report | SEC |
|---|
| NT 20-F | May 1, 2023 | Explanation request | SEC |
|---|
| SC 13D/A · Big-stake notice, amended | Apr 27, 2023 | Big-stake notice | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 18, 2023 | Current report | SEC |
|---|
| CERT · Exchange's certificate of listing | Apr 17, 2023 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 13, 2023 | Current report | SEC |
|---|
| RW · Request to withdraw a registration | Apr 13, 2023 | Other filings | SEC |
|---|
| CERT · Exchange's certificate of listing | Apr 12, 2023 | Other filings | SEC |
|---|
| 8-A12B · Registration of shares for listing on an exchange | Apr 11, 2023 | Other filings | SEC |
|---|
| FWP · Free writing prospectus | Apr 11, 2023 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 3, 2023 | Current report | SEC |
|---|
| EFFECT · Notice that a registration is effective | Apr 3, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 31, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 31, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 31, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 31, 2023 | Other filings | SEC |
|---|
| F-1/A · Registration statement, amended | Mar 27, 2023 | Offer document | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 23, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 23, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 23, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 23, 2023 | Other filings | SEC |
|---|
| FWP · Free writing prospectus | Mar 23, 2023 | Offer document | SEC |
|---|
| F-1/A · Registration statement, amended | Mar 22, 2023 | Offer document | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 17, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 17, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 17, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 17, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 13, 2023 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Mar 13, 2023 | Other filings | SEC |
|---|
| F-1/A · Registration statement, amended | Mar 13, 2023 | Offer document | SEC |
|---|
| FWP · Free writing prospectus | Mar 9, 2023 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Mar 9, 2023 | Current report | SEC |
|---|
| FWP · Free writing prospectus | Mar 8, 2023 | Offer document | SEC |
|---|
| F-1/A · Registration statement, amended | Mar 7, 2023 | Offer document | SEC |
|---|
| F-1/A · Registration statement, amended | Mar 1, 2023 | Offer document | SEC |
|---|
| F-1/A · Registration statement, amended | Feb 28, 2023 | Offer document | SEC |
|---|
| CORRESP · Letter to the SEC | Feb 28, 2023 | Other filings | SEC |
|---|
| UPLOAD · Letter from the SEC | Feb 24, 2023 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Feb 17, 2023 | Current report | SEC |
|---|
| F-1 · Registration statement | Feb 16, 2023 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 27, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 24, 2023 | Current report | SEC |
|---|
| SC 13D/A · Big-stake notice, amended | Jan 18, 2023 | Big-stake notice | SEC |
|---|
| 424B4 · Prospectus | Dec 28, 2022 | Offer document | SEC |
|---|
| EFFECT · Notice that a registration is effective | Dec 28, 2022 | Other filings | SEC |
|---|
| UPLOAD · Letter from the SEC | Dec 22, 2022 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Dec 22, 2022 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 19, 2022 | Current report | SEC |
|---|
| F-1 · Registration statement | Dec 16, 2022 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 5, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 30, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 9, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 24, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 24, 2022 | Current report | SEC |
|---|
| EFFECT · Notice that a registration is effective | Oct 3, 2022 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 29, 2022 | Current report | SEC |
|---|
| UPLOAD · Letter from the SEC | Sep 29, 2022 | Other filings | SEC |
|---|
| CORRESP · Letter to the SEC | Sep 29, 2022 | Other filings | SEC |
|---|
| F-3 · Registration statement | Sep 23, 2022 | Offer document | SEC |
|---|
| SC 13D/A · Big-stake notice, amended | Sep 13, 2022 | Big-stake notice | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 12, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Aug 30, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Aug 26, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 27, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 13, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 7, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 19, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 17, 2022 | Current report | SEC |
|---|
| 424B3 · Prospectus | May 17, 2022 | Offer document | SEC |
|---|
| SC 13D/A · Big-stake notice, amended | May 13, 2022 | Big-stake notice | SEC |
|---|
| EFFECT · Notice that a registration is effective | Apr 26, 2022 | Other filings | SEC |
|---|
| 424B3 · Prospectus | Apr 25, 2022 | Offer document | SEC |
|---|
| CORRESP · Letter to the SEC | Apr 22, 2022 | Other filings | SEC |
|---|
| UPLOAD · Letter from the SEC | Apr 20, 2022 | Other filings | SEC |
|---|
| EFFECT · Notice that a registration is effective | Apr 20, 2022 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 18, 2022 | Current report | SEC |
|---|
| F-3 · Registration statement | Apr 14, 2022 | Offer document | SEC |
|---|
| POS AM · Amendment to an effective registration | Apr 14, 2022 | Offer document | SEC |
|---|
| 20-F · Annual report | Apr 12, 2022 | Annual report | SEC |
|---|
| 6-K · Report of a foreign issuer | Mar 4, 2022 | Current report | SEC |
|---|
| EFFECT · Notice that a registration is effective | Feb 18, 2022 | Other filings | SEC |
|---|
| 424B3 · Prospectus | Feb 17, 2022 | Offer document | SEC |
|---|
| CORRESP · Letter to the SEC | Feb 15, 2022 | Other filings | SEC |
|---|
| UPLOAD · Letter from the SEC | Feb 14, 2022 | Other filings | SEC |
|---|
| F-1 · Registration statement | Feb 8, 2022 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Feb 8, 2022 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 16, 2021 | Current report | SEC |
|---|
| EFFECT · Notice that a registration is effective | Dec 9, 2021 | Other filings | SEC |
|---|
| 424B5 · Prospectus | Dec 8, 2021 | Offer document | SEC |
|---|
| CORRESP · Letter to the SEC | Dec 7, 2021 | Other filings | SEC |
|---|
| UPLOAD · Letter from the SEC | Nov 24, 2021 | Other filings | SEC |
|---|
| EFFECT · Notice that a registration is effective | Nov 24, 2021 | Other filings | SEC |
|---|
| F-3 · Registration statement | Nov 16, 2021 | Offer document | SEC |
|---|
| POS AM · Amendment to an effective registration | Nov 16, 2021 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 8, 2021 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 23, 2021 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 21, 2021 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 16, 2021 | Current report | SEC |
|---|
| EFFECT · Notice that a registration is effective | Jun 8, 2021 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 3, 2021 | Current report | SEC |
|---|
| POS AM · Amendment to an effective registration | Jun 2, 2021 | Offer document | SEC |
|---|
| POS AM · Amendment to an effective registration | Jun 2, 2021 | Offer document | SEC |
|---|
| SC 13D/A · Big-stake notice, amended | May 21, 2021 | Big-stake notice | SEC |
|---|
| 6-K · Report of a foreign issuer | May 17, 2021 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 16, 2021 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 13, 2021 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Mar 31, 2021 | Current report | SEC |
|---|
| 20-F · Annual report | Mar 31, 2021 | Annual report | SEC |
|---|
| 6-K · Report of a foreign issuer | Mar 12, 2021 | Current report | SEC |
|---|
| SC 13G/A · Big-stake notice, amended | Feb 12, 2021 | Big-stake notice | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 15, 2021 | Current report | SEC |
|---|
| 424B5 · Prospectus | Jan 15, 2021 | Offer document | SEC |
|---|
| S-8 · Registration statement for employee plans | Jan 15, 2021 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 10, 2020 | Current report | SEC |
|---|
| SC 13D/A · Big-stake notice, amended | Dec 7, 2020 | Big-stake notice | SEC |
|---|
This page holds 200 of 518 filings. Open Filings
Open Filings · All of its filings on SEC EDGAR
Cap table
Built by 6ix from Altamira Therapeutics Ltd.’s releases
- Common shares
- 5,715,472
- Fully diluted
- 5,715,472
Fully diluted
| Line | Shares |
|---|
| Common shares | 5,715,472 |
|---|
Share count over time
| Count | Shares |
|---|
| Nov 22, 2026 | 5,715,472 |
|---|
Open Cap table
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|
| Alain Munoz | Director · Since at least Nov 5, 2026 |
|---|
| Covadonga Pañeda | Chief Operating Officer · Since at least Nov 4, 2026 |
|---|
| Dominik Lysek | Director · Since at least Nov 5, 2026 |
|---|
| Marcel Gremaud | Chief Financial Officer · Since at least Nov 4, 2026 |
|---|
| Samuel A. Wickline | Chief Scientific Adviser · Since at least Nov 4, 2026 |
|---|
| Thomas Meyer | Chairman of the Board, Chief Executive Officer · Since at least Nov 5, 2026 |
|---|
Open People
Log in to ask 6ix AI your own questions about Altamira Therapeutics Ltd.